Clinic
Contra Costa County
Contra Costa County was paid $202.20M by Medicaid between Jan 2018 and Dec 2024, across 280 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 80% of everything it billed.
33Billing provider infoCONTRA COSTA COUNTY
PITTSBURG, CA 94565
PITTSBURG, CA 94565
33aNPI1568540763assigned 11/02/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$202.20M
24GClaims2,525,560
24DCodes billed280
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in California
Rank by total paid#4 of 826
Median peer was paid$4.05M
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LEE, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 238,497 | $32.27M | |
| 2019 | 269,197 | $27.49M | |
| 2020 | 329,095 | $26.47M | |
| 2021 | 459,434 | $33.16M | |
| 2022 | 380,262 | $25.08M | |
| 2023 | 404,956 | $28.22M | |
| 2024incomplete | 444,119 | $29.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 80% | 470,230 | 417,876 | $160.82M |
| 0510 | 15% | 371,708 | 345,446 | $30.28M | |
| 00003 | Internal/system code - not a standard HCPCS code | 3.7% | 17,655 | 14,708 | $7.56M |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 9,501 | 8,671 | $1.83M |
| 99078 | <1% | 15,094 | 5,704 | $452K | |
| 96164 | <1% | 10,878 | 1,069 | $232K | |
| 0002A | <1% | 9,851 | 7,438 | $194K | |
| 0001A | <1% | 10,603 | 7,658 | $186K | |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 3,573 | 771 | $86K |
| 96152 | <1% | 2,398 | 523 | $70K | |
| 0004A | <1% | 1,384 | 1,384 | $55K | |
| 96158 | <1% | 2,422 | 367 | $49K |
268 more codes
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,811 | $45K |
| 0054A | <1% | 1,097 | $45K | |
| 0124A | <1% | 727 | $34K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,016 | $32K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 560 | $23K |
| 0064A | <1% | 565 | $22K | |
| 0011A | <1% | 1,680 | $19K | |
| 0012A | <1% | 1,665 | $18K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 295,959 | $15K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12,680 | $14K |
| S0197 | Prenatal vitamins, 30-day supply | <1% | 1,404 | $14K |
| 0071A | <1% | 339 | $13K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 322 | $12K |
| 0052A | <1% | 220 | $9K | |
| 96159 | <1% | 2,118 | $8K | |
| 99401 | <1% | 320 | $7K | |
| 0134A | <1% | 105 | $7K | |
| 91322 | <1% | 249 | $6K | |
| Z7500 | <1% | 241,069 | $5K | |
| 0051A | <1% | 123 | $5K | |
| 0003A | <1% | 116 | $5K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 151 | $4K |
| 90480 | <1% | 664 | $4K | |
| 0013A | <1% | 72 | $3K | |
| 0072A | <1% | 55 | $3K | |
| 0081A | <1% | 38 | $2K | |
| 0082A | <1% | 36 | $2K | |
| 0074A | <1% | 35 | $2K | |
| 96153 | <1% | 2,436 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 82,204 | $1K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 44 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 9,811 | $948.03 |
| 0154A | <1% | 14 | $938.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 72,268 | $498.23 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 906 | $260.52 |
| 83721 | <1% | 13,596 | $175.84 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,011 | $158.78 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,931 | $146.58 |
| 85027 | <1% | 15,255 | $116.80 | |
| Q3014 | Telehealth originating site facility fee | <1% | 119,349 | $109.50 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 5,291 | $103.87 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,217 | $103.86 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 49,454 | $100.20 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,671 | $93.24 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 36,771 | $82.04 |
| 90739 | <1% | 4,728 | $77.42 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,237 | $58.70 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,909 | $58.34 |
| 84132 | <1% | 285 | $55.30 | |
| 82565 | <1% | 2,281 | $55.30 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,890 | $51.72 |
| 80053 | Comprehensive metabolic panel | <1% | 18,857 | $47.03 |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 11,254 | $37.15 |
| 82607 | <1% | 2,590 | $34.70 | |
| 86803 | <1% | 2,248 | $34.05 | |
| 81002 | <1% | 25,550 | $23.00 | |
| 84520 | <1% | 249 | $20.30 | |
| 80061 | Lipid panel | <1% | 6,238 | $18.58 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,280 | $12.79 |
| 86364 | <1% | 277 | $11.53 | |
| 82784 | <1% | 376 | $6.08 | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 12,609 | $2.94 |
| 83718 | <1% | 6,871 | $1.99 | |
| 82465 | <1% | 6,790 | $1.81 | |
| 86706 | <1% | 416 | $0.88 | |
| 84550 | <1% | 797 | $0.37 | |
| 86592 | <1% | 2,097 | $0.35 | |
| Z7610 | 0% | 6,197 | $0.00 | |
| Z1034 | 0% | 15,018 | $0.00 | |
| 81001 | 0% | 1,009 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 48,036 | $0.00 |
| Z6402 | 0% | 1,040 | $0.00 | |
| 90688 | 0% | 155 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 6,231 | $0.00 |
| 88142 | 0% | 1,897 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 2,757 | $0.00 |
| 97139 | 0% | 301 | $0.00 | |
| Z6406 | 0% | 3,252 | $0.00 | |
| 87625 | 0% | 802 | $0.00 | |
| 90686 | 0% | 39,521 | $0.00 | |
| 86901 | 0% | 1,817 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 3,092 | $0.00 |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 0% | 1,964 | $0.00 |
| 99241 | 0% | 1,030 | $0.00 | |
| 90619 | 0% | 872 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 5,238 | $0.00 |
| 86850 | 0% | 1,817 | $0.00 | |
| 90680 | 0% | 2,965 | $0.00 | |
| 90656 | 0% | 5,771 | $0.00 | |
| 87340 | 0% | 1,564 | $0.00 | |
| 85652 | 0% | 2,105 | $0.00 | |
| 90698 | 0% | 3,491 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 1,257 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 2,938 | $0.00 |
| 90744 | 0% | 1,836 | $0.00 | |
| 11106 | 0% | 109 | $0.00 | |
| 86762 | 0% | 1,441 | $0.00 | |
| 88720 | 0% | 5,098 | $0.00 | |
| 0271 | 0% | 1,708 | $0.00 | |
| 90677 | 0% | 1,975 | $0.00 | |
| 90697 | 0% | 1,155 | $0.00 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 0% | 135 | $0.00 |
| 92002 | 0% | 2,131 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 1,339 | $0.00 |
| Z6404 | 0% | 1,169 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 524 | $0.00 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 0% | 3,855 | $0.00 |
| 86355 | 0% | 233 | $0.00 | |
| 86141 | 0% | 345 | $0.00 | |
| 82043 | 0% | 1,324 | $0.00 | |
| 99205 | Prolong outpt/office vis | 0% | 2,023 | $0.00 |
| 92567 | 0% | 1,564 | $0.00 | |
| 83520 | 0% | 176 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 1,889 | $0.00 |
| 85018 | 0% | 807 | $0.00 | |
| X6218 | 0% | 12 | $0.00 | |
| 83735 | 0% | 282 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 390 | $0.00 |
| 86160 | 0% | 256 | $0.00 | |
| 82105 | 0% | 791 | $0.00 | |
| 87536 | 0% | 253 | $0.00 | |
| 84478 | 0% | 60 | $0.00 | |
| 20610 | 0% | 858 | $0.00 | |
| 86704 | 0% | 410 | $0.00 | |
| 90696 | 0% | 390 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 50 | $0.00 |
| 97750 | 0% | 52 | $0.00 | |
| 82728 | 0% | 1,507 | $0.00 | |
| 99243 | 0% | 295 | $0.00 | |
| 82670 | 0% | 349 | $0.00 | |
| 86481 | 0% | 132 | $0.00 | |
| 83519 | 0% | 41 | $0.00 | |
| 90674 | 0% | 139 | $0.00 | |
| 86225 | 0% | 151 | $0.00 | |
| 90651 | 0% | 870 | $0.00 | |
| 99384 | 0% | 29 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 461 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 25 | $0.00 |
| 90716 | 0% | 184 | $0.00 | |
| 90647 | 0% | 42 | $0.00 | |
| 0636 | 0% | 13 | $0.00 | |
| Z1032 | 0% | 41 | $0.00 | |
| 99381 | 0% | 20 | $0.00 | |
| D1310 | 0% | 138 | $0.00 | |
| 86800 | 0% | 25 | $0.00 | |
| 90732 | 0% | 52 | $0.00 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 50 | $0.00 |
| 0761 | 0% | 94 | $0.00 | |
| 82985 | 0% | 40 | $0.00 | |
| 83921 | 0% | 43 | $0.00 | |
| 0700 | 0% | 32 | $0.00 | |
| Z1038 | 0% | 60 | $0.00 | |
| 0031A | 0% | 70 | $0.00 | |
| 86376 | 0% | 25 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 21 | $0.00 |
| Z6204 | 0% | 14 | $0.00 | |
| Z6410 | 0% | 26 | $0.00 | |
| 96150 | 0% | 28 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 26 | $0.00 |
| 87081 | 0% | 22 | $0.00 | |
| 83986 | 0% | 13 | $0.00 | |
| 90620 | 0% | 16 | $0.00 | |
| 11055 | 0% | 25 | $0.00 | |
| 84402 | 0% | 13 | $0.00 | |
| 82746 | 0% | 13 | $0.00 | |
| 84703 | 0% | 12 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 2,796 | $0.00 |
| 84460 | 0% | 2,249 | $0.00 | |
| 80076 | 0% | 2,980 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 15,798 | $0.00 |
| Z6300 | 0% | 1,034 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 96,259 | $0.00 |
| 92557 | 0% | 1,233 | $0.00 | |
| 83068 | 0% | 255 | $0.00 | |
| 82274 | 0% | 131 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 13,450 | $0.00 |
| 86900 | 0% | 1,816 | $0.00 | |
| 95801 | 0% | 1,905 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 1,262 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 14,302 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 8,951 | $0.00 |
| 97811 | 0% | 4,849 | $0.00 | |
| 83655 | 0% | 1,175 | $0.00 | |
| 90715 | 0% | 3,169 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 2,838 | $0.00 |
| 90670 | 0% | 6,901 | $0.00 | |
| 0272 | 0% | 2,402 | $0.00 | |
| 86708 | 0% | 384 | $0.00 | |
| 86200 | 0% | 231 | $0.00 | |
| 90750 | 0% | 1,197 | $0.00 | |
| 81025 | 0% | 508 | $0.00 | |
| 11056 | 0% | 1,266 | $0.00 | |
| Z6200 | 0% | 1,020 | $0.00 | |
| 82947 | 0% | 390 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 3,557 | $0.00 |
| 90649 | 0% | 4,029 | $0.00 | |
| 86787 | 0% | 1,261 | $0.00 | |
| 86431 | 0% | 336 | $0.00 | |
| 98940 | 0% | 7,617 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 3,344 | $0.00 |
| 81003 | 0% | 995 | $0.00 | |
| Z6414 | 0% | 105 | $0.00 | |
| 90633 | 0% | 6,546 | $0.00 | |
| 84466 | 0% | 652 | $0.00 | |
| 82570 | 0% | 1,502 | $0.00 | |
| 94060 | 0% | 856 | $0.00 | |
| Z6500 | 0% | 778 | $0.00 | |
| 90685 | 0% | 44 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 2,337 | $0.00 |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 328 | $0.00 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 0% | 85 | $0.00 |
| 85014 | 0% | 134 | $0.00 | |
| 83540 | 0% | 692 | $0.00 | |
| 99201 | 0% | 2,892 | $0.00 | |
| 86480 | 0% | 223 | $0.00 | |
| 98926 | 0% | 2,554 | $0.00 | |
| 99242 | 0% | 470 | $0.00 | |
| 90710 | 0% | 2,594 | $0.00 | |
| 84450 | 0% | 1,107 | $0.00 | |
| 96165 | 0% | 10,608 | $0.00 | |
| 99188 | 0% | 593 | $0.00 | |
| 59425 | 0% | 1,852 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 107 | $0.00 |
| Z6400 | 0% | 2,403 | $0.00 | |
| 11721 | 0% | 2,908 | $0.00 | |
| 90671 | 0% | 1,107 | $0.00 | |
| 86038 | 0% | 398 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 542 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 26 | $0.00 |
| 81329 | 0% | 490 | $0.00 | |
| 85610 | 0% | 609 | $0.00 | |
| 97810 | 0% | 4,185 | $0.00 | |
| 90700 | 0% | 209 | $0.00 | |
| 97161 | 0% | 29 | $0.00 | |
| 83013 | 0% | 167 | $0.00 | |
| 86359 | 0% | 233 | $0.00 | |
| 84155 | 0% | 187 | $0.00 | |
| 90734 | 0% | 56 | $0.00 | |
| S4993 | Contraceptive pills for birth control | 0% | 268 | $0.00 |
| 92588 | 0% | 167 | $0.00 | |
| V5060 | Hearing aid, monaural, behind the ear | 0% | 131 | $0.00 |
| 73630 | 0% | 910 | $0.00 | |
| 84165 | 0% | 187 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 351 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 66 | $0.00 |
| 87338 | 0% | 24 | $0.00 | |
| V5010 | Assessment for hearing aid | 0% | 67 | $0.00 |
| 86682 | 0% | 127 | $0.00 | |
| 90662 | 0% | 80 | $0.00 | |
| 86360 | 0% | 131 | $0.00 | |
| 92579 | 0% | 30 | $0.00 | |
| 94727 | 0% | 58 | $0.00 | |
| 94729 | 0% | 58 | $0.00 | |
| 80365 | 0% | 37 | $0.00 | |
| 80348 | 0% | 83 | $0.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 27 | $0.00 |
| 20605 | 0% | 246 | $0.00 | |
| 85045 | 0% | 15 | $0.00 | |
| 80361 | 0% | 37 | $0.00 | |
| 90707 | 0% | 121 | $0.00 | |
| 90658 | 0% | 31 | $0.00 | |
| 84425 | 0% | 26 | $0.00 | |
| 86235 | 0% | 39 | $0.00 | |
| Z6304 | 0% | 14 | $0.00 | |
| 87210 | 0% | 71 | $0.00 | |
| 11750 | 0% | 53 | $0.00 | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 0% | 95 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEE, DAVID (DEPUTY CFO)
Parent organizationCONTRA COSTA COUNTY
| Provider | Location | Paid |
|---|---|---|
| Contra Costa County | Martinez, CA | $536.98M |
| Contra Costa County | San Pablo, CA | $170.81M |
| Contra Costa County | Martinez, CA | $100.64M |
| Contra Costa County | Martinez, CA | $90.59M |
| Contra Costa County | Concord, CA | $83.05M |
| Contra Costa County | Antioch, CA | $65.79M |
| Contra Costa County | Martinez, CA | $64.10M |
| Contra Costa County | Brentwood, CA | $45.11M |
| Contra Costa County | Concord, CA | $33.14M |
| Lone Star Ambulance 1, LLC | Corpus Christi, TX | $31.57M |
| Contra Costa County | Martinez, CA | $30.20M |
| Contra Costa County | San Pablo, CA | $28.69M |
| Contra Costa County | Pittsburg, CA | $24.26M |
| Contra Costa County | Concord, CA | $19.55M |
| Contra Costa County | Antioch, CA | $17.16M |
| Contra Costa County | Martinez, CA | $15.98M |
| Contra Costa County | North Richmond, CA | $14.20M |
| Contra Costa County | San Pablo, CA | $13.26M |
| Contra Costa County | Bay Point, CA | $10.44M |
| Contra Costa County | Martinez, CA | $7.24M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.